Efonidipine hydrochloride: A dual blocker of L- and T-type Ca2+ channels

Cardiovascular Drug Reviews

Volumn 20, Issue 1, 2002, Pages 81-92

  Tanaka, Hikaru ^a   Shigenobu, Koki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Angina pectoris; Ca2+ channels; Calcium antagonists; Efonidipine; Hypertension; L type Ca2+ channels; T type Ca2+ channels

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; EFONIDIPINE;

ANGINA PECTORIS; ARTERIOLE; BLOOD FLOW; BLOOD PRESSURE; CHRONOTROPISM; GLOMERULUS FILTRATION RATE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HUMAN; HYPERTENSION; INOTROPISM; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SINUS NODE; VASODILATATION;

EID: 0036082788     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2002.tb00084.x     Document Type: Review

References (68)

1. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue
2. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker
3. 2+ channels and heart failure
4. 2+ channel gene family
5. Vascular smooth muscle calcium channels: Could "T" be a target?
6. A mathematical model of a rabbit sinoatrial node cell
7. 2+ channels
8. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs
9. Ryanodine receptors of striated muscles: A complex channel capable of multiple interactions
10. Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs
11. Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs
12. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats
13. 2+ channels by amlodipine
14. Influence of heart rate on mortality among persons with hypertension: The Framingham Study
15. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atri0al node cells
16. Control of heart rate in the treatment of hypertension: A new trend in calcium antagonists
17. T-type and L-type voltage-dependent calcium channels (VDCC) are differentially expressed in renal resistance vessels
18. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels
19. Disparate effects of calcium antagonists on renal microcirculation
20. Physiologic and pathophysiologic relevance of T-type calcium-ion channels: Potential indications for T-type calcium antagonists
21. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: Comparison with effects of nifedipine and nisoldipine
22. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo
23. 2+ channel gene and current in post-infarction remodeled rat left ventricle
24. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: Comparison with the effects of nifedipine and nisoldipine
25. 2+ current
26. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury
27. Effects of a newly synthesized dihydropyridine, NZ-105, on intracellular Ca transients and tension in ferret ventricular muscles
28. T-type calcium currents in rat cardiomyocytes during postnatal development: Contribution to hormone secretion
29. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta
30. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro
31. Efonidipine hydrochloride: A new calcium antagonist
32. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues
33. 2- channel antagonists on sinus node: Prolongation of late phase 4 depolarization by efonidipine
34. 2+ currents by efonidipine: Possible mechanism for its chronotropic effect
35. 2+ channel antagonist, on sino-atrial node and ventricular myocardia
36. 2+ current by efonidipine in cardiomyocytes
37. Possible requirement of phosphonate moiety for efonidipine effects on the sino-atrial node action potential
38. 2+ transients in rat atrial and ventricular cardiomyocytes
39. 2+ channels by Ro 40-5967
40. +-channel blocking agents on calcium transients and tension development in isolated mammalian heart muscle
41. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes
42. Pharmacological properties of the human cloned T-type calcium channel
43. Analysis of the negative chronotropic action of efonidipine in rabbit sinoatrial node cells
44. Effect of T-type selective calcium antagonist on renal microcirculation: Studies in the isolated perfused hydronephrotic kidney
45. Three for T: Molecular analysis of the low voltage-activated calcium channel family
46. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina
47. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists
48. Long-term comparison of renal function between efonidipine hydrochloride and ACE inhibitor for hypertensive patients complicated by renal disorders
49. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel
50. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts
51. Effect of efonidipine hydrochloride, dihydropyridine Ca antagonist with T-type calcium channel blocking action, on heart rate
52. Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits
53. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats
54. 2+ release from the sarcoplasmic reticulum in guinea-pig ventricular myocytes
55. Effects of the antihypertensive drug efonidipine hydrochloride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes
56. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem
57. 2+ parks in rat cardiomyocytes
58. AHC-52, a dihydropyridine compound with chloride current blocking and cardioprotective activities
59. 2+ waves in excitation-contraction coupling of rat atrial cardiomyocytes
60. 2+ channels distributed in cardiovascular system
61. T-channel-selective calcium channel blockade: A promising therapeutic possibility, only preliminarily tested so far: A review of published data
62. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats
63. Clinical evaluation of efonidipine hydrochloride (NZ-105) on exercise tolerance in patients with angina pectoris
64. Efficacy and safety of the long-term treatment with NZ-105 for essential hypertension
65. NZ-105, a new 1,4-dihydropyridine derivative: Correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta
66. Effects of efonidipine hydrochloride on the glomerular hemodynamics
67. Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs
68. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: Comparison with nifedipine